Rolf W. Sparidans
- Oncology top 1%
- Molecular Biology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Genetics top 2%
- Pharmacology top 0.5%
- Co-authors
- Jos H. BeijnenAlfred H. SchinkelJan H.M. SchellensEls WagenaarIrene van den BroekJurjen S. LagasSelvi DurmuşJan den Hartigh
- Topics
- Drug Transport and Resistance Mechanisms (41 papers)Cancer therapeutics and mechanisms (23 papers)HIV/AIDS drug development and treatment (21 papers)
- Cited by
- OncologyPharmacologyGenetics
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaCancer Research
- Partner nations
- NetherlandsSpainUnited States
In The Last Decade
Rolf W. Sparidans
167 papers receiving 4.1k citations
Peers
Comparison fields: 5 of 123
- Oncology 2.0k
- Molecular Biology 1.6k
- Pulmonary and Respiratory Medicine 631
- Genetics 436
- Pharmacology 426
Countries citing papers authored by Rolf W. Sparidans
This map shows the geographic impact of Rolf W. Sparidans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rolf W. Sparidans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rolf W. Sparidans more than expected).
Fields of papers citing papers by Rolf W. Sparidans
This network shows the impact of papers produced by Rolf W. Sparidans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rolf W. Sparidans. The network helps show where Rolf W. Sparidans may publish in the future.
Co-authorship network of co-authors of Rolf W. Sparidans
This figure shows the co-authorship network connecting the top 25 collaborators of Rolf W. Sparidans. A scholar is included among the top collaborators of Rolf W. Sparidans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rolf W. Sparidans. Rolf W. Sparidans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 9 | |
| 4 | 2 | |
| 5 | 7 | |
| 6 | 7 | |
| 7 | 19 | |
| 8 | 15 | |
| 9 | 10 | |
| 10 | 23 | |
| 11 | 64 | |
| 12 | 39 | |
| 13 | 31 | |
| 14 | 47 | |
| 15 | 41 | |
| 16 | 31 | |
| 17 | 130 | |
| 18 | 102 | |
| 19 | 151 | |
| 20 | 17 |
About Rolf W. Sparidans
Rolf W. Sparidans is a scholar working on Oncology, Pharmacology and Virology, having authored 169 papers that have together received 4.2k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (41 papers), Cancer therapeutics and mechanisms (23 papers) and HIV/AIDS drug development and treatment (21 papers). The work is most often cited by research in Oncology (2.0k citations), Pharmacology (426 citations) and Genetics (436 citations). Rolf W. Sparidans has collaborated with scholars based in Netherlands, Spain and United States. Frequent co-authors include Jos H. Beijnen, Alfred H. Schinkel, Jan H.M. Schellens, Els Wagenaar, Irene van den Broek, Jurjen S. Lagas, Selvi Durmuş, Jan den Hartigh, Robert A.B. van Waterschoot and Johannes J.M. Rood. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.